Mallet Finger Splinting Study

Not Applicable

Completed

• Conditions: Mallet Finger
• Interventions: Procedure: night splinting

• Registration Number: NCT01388751
• Lead Sponsor: Massachusetts General Hospital

Brief Summary

Do patients that night splint for 1 month after 6-8 weeks of continuous splinting for a mallet injury have the same extensor lag 4 months after initiating treatment as patients that do not perform night splinting?

Secondary Question: Is night splinting a predictor of DASH score or patient satisfaction (on a 5-Point Likert scale)?

Detailed Description

Not available

Study Timeline

• Study Start: 2008-11
• Study First Submitted: 2011-07-05
• Study First Submitted QC: 2011-07-06
• Study First Posted: 2011-07-07
• Primary Completion: 2012-05
• Study Completion: 2012-09
• Status Verified: 2012-10
• Last Update Submitted: 2012-10-30
• Last Update Posted: 2012-10-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

• All adult, English-speaking patients in the practice of Dr. Jesse Jupiter, Dr. Chaitanya Mudgal, or Dr. David Ring electing splint treatment for mallet deformity will be invited to enroll on their follow-up visit 6-8 weeks after initiating splint treatment.

Exclusion Criteria

1. Open lesions
2. Mallet fracture more than 2 weeks old
3. Mallet fracture with subluxation of the distal interphalangeal joint.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
night splinting	night splinting	Night Splinting for 4 weeks after removal of initial cast

Primary Outcome Measures

Name	Time	Method
Extensor Lag	4 months	Null Hypothesis: Patients that night splint for 1 month after 6-8 weeks of continuous splinting for a mallet injury have the same extensor lag 4 months after initiating treatment as patients that do not perform night splinting.

Secondary Outcome Measures

Name	Time	Method
DASH score	4 months	Secondary Study Questions: Is night splinting a predictor of DASH score or patient satisfaction (on a 5-Point Likert scale)?

Trial Locations

Locations (1)

Massachusetts General Hospital; 🇺🇸 Boston, Massachusetts, United States